• Je něco špatně v tomto záznamu ?

Local endothelial DNA repair deficiency causes aging-resembling endothelial-specific dysfunction

PK. Bautista-Niño, E. Portilla-Fernandez, E. Rubio-Beltrán, JJ. van der Linden, R. de Vries, R. van Veghel, M. de Boer, M. Durik, Y. Ridwan, R. Brandt, J. Essers, RI. Menzies, R. Thomas, A. de Bruin, DJ. Duncker, HMM. van Beusekom, M. Ghanbari,...

. 2020 ; 134 (7) : 727-746. [pub] 20200417

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025080

Grantová podpora
CH/12/4/29762 British Heart Foundation - United Kingdom
FS/15/60/31510 British Heart Foundation - United Kingdom
P01 AG017242 NIA NIH HHS - United States

We previously identified genomic instability as a causative factor for vascular aging. In the present study, we determined which vascular aging outcomes are due to local endothelial DNA damage, which was accomplished by genetic removal of ERCC1 (excision repair cross-complementation group 1) DNA repair in mice (EC-knockout (EC-KO) mice). EC-KO showed a progressive decrease in microvascular dilation of the skin, increased microvascular leakage in the kidney, decreased lung perfusion, and increased aortic stiffness compared with wild-type (WT). EC-KO showed expression of DNA damage and potential senescence marker p21 exclusively in the endothelium, as demonstrated in aorta. Also the kidney showed p21-positive cells. Vasodilator responses measured in organ baths were decreased in aorta, iliac and coronary artery EC-KO compared with WT, of which coronary artery was the earliest to be affected. Nitric oxide-mediated endothelium-dependent vasodilation was abolished in aorta and coronary artery, whereas endothelium-derived hyperpolarization and responses to exogenous nitric oxide (NO) were intact. EC-KO showed increased superoxide production compared with WT, as measured in lung tissue, rich in endothelial cells (ECs). Arterial systolic blood pressure (BP) was increased at 3 months, but normal at 5 months, at which age cardiac output (CO) was decreased. Since no further signs of cardiac dysfunction were detected, this decrease might be an adaptation to prevent an increase in BP. In summary, a selective DNA repair defect in the endothelium produces features of age-related endothelial dysfunction, largely attributed to loss of endothelium-derived NO. Increased superoxide generation might contribute to the observed changes affecting end organ perfusion, as demonstrated in kidney and lung.

Centre for Cardiovascular Science The University of Edinburgh Edinburgh U K

Department of Epidemiology Erasmus University Medical Center Rotterdam The Netherlands

Department of Molecular Genetics Erasmus University Medical Center Rotterdam The Netherlands

Department of Molecular Genetics Erasmus University Medical Center Rotterdam The Netherlands CECAD Forschungszentrum Universität zu Köln Cologne Germany Princess Máxima Center for Pediatric Oncology ONCODE Institute Utrecht The Netherlands

Department of Molecular Genetics Erasmus University Medical Center Rotterdam The Netherlands Department of Radiology and Nuclear Medicine Erasmus University Medical Center Rotterdam The Netherlands

Department of Molecular Genetics Erasmus University Medical Center Rotterdam The Netherlands Department of Radiology and Nuclear Medicine Erasmus University Medical Center Rotterdam The Netherlands Department of Vascular Surgery Erasmus University Medical Center Rotterdam The Netherlands

Department of Molecular Genetics Erasmus University Medical Center Rotterdam The Netherlands Department of Vascular Surgery Erasmus University Medical Center Rotterdam The Netherlands

Division of Experimental Cardiology Department of Cardiology Thoraxcenter Erasmus University Medical Center Rotterdam The Netherlands

Division of Vascular Medicine and Pharmacology Department of Internal Medicine Erasmus University Medical Center Rotterdam The Netherlands

Division of Vascular Medicine and Pharmacology Department of Internal Medicine Erasmus University Medical Center Rotterdam The Netherlands Department of Clinical Experimental Research Glostrup Research Institute Copenhagen University Hospital Copenhagen Denmark

Division of Vascular Medicine and Pharmacology Department of Internal Medicine Erasmus University Medical Center Rotterdam The Netherlands Department of Epidemiology Erasmus University Medical Center Rotterdam The Netherlands

Division of Vascular Medicine and Pharmacology Department of Internal Medicine Erasmus University Medical Center Rotterdam The Netherlands Department of Molecular Genetics Erasmus University Medical Center Rotterdam The Netherlands

Division of Vascular Medicine and Pharmacology Department of Internal Medicine Erasmus University Medical Center Rotterdam The Netherlands Department of Pediatric and Adolescent Medicine Mayo Clinic College of Medicine Rochester MN U S A

Division of Vascular Medicine and Pharmacology Department of Internal Medicine Erasmus University Medical Center Rotterdam The Netherlands Fundacion Cardiovascular de Colombia FCV Dept of Cardiology Bucaramanga Colombia

Dutch Molecular Pathology Centre Faculty of Veterinary Medicine Department of Pathobiology Utrecht University Utrecht The Netherlands

Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow U K

Laboratory of Transgenic Models of Diseases and Czech Centre for Phenogenomics Institute of Molecular Genetics of the ASCR Prague Czech Republic

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025080
003      
CZ-PrNML
005      
20201222153656.0
007      
ta
008      
201125s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1042/CS20190124 $2 doi
035    __
$a (PubMed)32202295
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Bautista-Niño, Paula K $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Fundacion Cardiovascular de Colombia FCV, Dept. of Cardiology, Bucaramanga, Colombia.
245    10
$a Local endothelial DNA repair deficiency causes aging-resembling endothelial-specific dysfunction / $c PK. Bautista-Niño, E. Portilla-Fernandez, E. Rubio-Beltrán, JJ. van der Linden, R. de Vries, R. van Veghel, M. de Boer, M. Durik, Y. Ridwan, R. Brandt, J. Essers, RI. Menzies, R. Thomas, A. de Bruin, DJ. Duncker, HMM. van Beusekom, M. Ghanbari, JHJ. Hoeijmakers, R. Sedlacek, RM. Touyz, AC. Montezano, I. van der Pluijm, AHJ. Danser, KA. Haanes, AJM. Roks,
520    9_
$a We previously identified genomic instability as a causative factor for vascular aging. In the present study, we determined which vascular aging outcomes are due to local endothelial DNA damage, which was accomplished by genetic removal of ERCC1 (excision repair cross-complementation group 1) DNA repair in mice (EC-knockout (EC-KO) mice). EC-KO showed a progressive decrease in microvascular dilation of the skin, increased microvascular leakage in the kidney, decreased lung perfusion, and increased aortic stiffness compared with wild-type (WT). EC-KO showed expression of DNA damage and potential senescence marker p21 exclusively in the endothelium, as demonstrated in aorta. Also the kidney showed p21-positive cells. Vasodilator responses measured in organ baths were decreased in aorta, iliac and coronary artery EC-KO compared with WT, of which coronary artery was the earliest to be affected. Nitric oxide-mediated endothelium-dependent vasodilation was abolished in aorta and coronary artery, whereas endothelium-derived hyperpolarization and responses to exogenous nitric oxide (NO) were intact. EC-KO showed increased superoxide production compared with WT, as measured in lung tissue, rich in endothelial cells (ECs). Arterial systolic blood pressure (BP) was increased at 3 months, but normal at 5 months, at which age cardiac output (CO) was decreased. Since no further signs of cardiac dysfunction were detected, this decrease might be an adaptation to prevent an increase in BP. In summary, a selective DNA repair defect in the endothelium produces features of age-related endothelial dysfunction, largely attributed to loss of endothelium-derived NO. Increased superoxide generation might contribute to the observed changes affecting end organ perfusion, as demonstrated in kidney and lung.
650    _2
$a věkové faktory $7 D000367
650    _2
$a stárnutí $x genetika $x metabolismus $x patologie $7 D000375
650    _2
$a zvířata $7 D000818
650    _2
$a kapilární permeabilita $7 D002199
650    _2
$a stárnutí buněk $x genetika $7 D016922
650    _2
$a inhibitor p21 cyklin-dependentní kinasy $x genetika $x metabolismus $7 D050759
650    12
$a poškození DNA $7 D004249
650    12
$a oprava DNA $7 D004260
650    _2
$a DNA vazebné proteiny $x nedostatek $x genetika $7 D004268
650    _2
$a endonukleasy $x nedostatek $x genetika $7 D004720
650    _2
$a endoteliální buňky $x metabolismus $x patologie $7 D042783
650    _2
$a cévní endotel $x metabolismus $x patologie $x patofyziologie $7 D004730
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a synthasa oxidu dusnatého, typ III $x metabolismus $7 D052250
650    _2
$a superoxidy $x metabolismus $7 D013481
650    _2
$a tuhost cévní stěny $7 D059289
650    _2
$a vazodilatace $7 D014664
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Portilla-Fernandez, Eliana $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Rubio-Beltrán, Eloisa $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a van der Linden, Janette J $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a de Vries, René $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a van Veghel, Richard $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a de Boer, Martine $u Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Durik, Matej $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN, U.S.A.
700    1_
$a Ridwan, Yanto $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Brandt, Renata $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Essers, Jeroen $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Menzies, Robert I $u Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, U.K.
700    1_
$a Thomas, Rachel $u Dutch Molecular Pathology Centre, Faculty of Veterinary Medicine, Department of Pathobiology, Utrecht University, Utrecht, The Netherlands.
700    1_
$a de Bruin, Alain $u Dutch Molecular Pathology Centre, Faculty of Veterinary Medicine, Department of Pathobiology, Utrecht University, Utrecht, The Netherlands.
700    1_
$a Duncker, Dirk J $u Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a van Beusekom, Heleen M M $u Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Ghanbari, Mohsen $u Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Hoeijmakers, Jan H J $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. CECAD Forschungszentrum, Universität zu Köln, Cologne, Germany. Princess Máxima Center for Pediatric Oncology, ONCODE Institute, Utrecht, The Netherlands.
700    1_
$a Sedlacek, Radislav $u Laboratory of Transgenic Models of Diseases and Czech Centre for Phenogenomics, Institute of Molecular Genetics of the ASCR, Prague, Czech Republic.
700    1_
$a Touyz, Rhian M $u Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.
700    1_
$a Montezano, Augusto C $u Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.
700    1_
$a van der Pluijm, Ingrid $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Danser, A H Jan $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Haanes, Kristian A $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Clinical Experimental Research, Glostrup Research Institute, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a Roks, Anton J M $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
773    0_
$w MED00009494 $t Clinical science (London, England : 1979) $x 1470-8736 $g Roč. 134, č. 7 (2020), s. 727-746
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32202295 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222153652 $b ABA008
999    __
$a ok $b bmc $g 1599225 $s 1115766
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 134 $c 7 $d 727-746 $e 20200417 $i 1470-8736 $m Clinical science (1979) $n Clin Sci (Lond) $x MED00009494
GRA    __
$a CH/12/4/29762 $p British Heart Foundation $2 United Kingdom
GRA    __
$a FS/15/60/31510 $p British Heart Foundation $2 United Kingdom
GRA    __
$a P01 AG017242 $p NIA NIH HHS $2 United States
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace